Compare Cadila Healthcare with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs TTK HEALTHCARE - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE TTK HEALTHCARE CADILA HEALTHCARE/
TTK HEALTHCARE
 
P/E (TTM) x 14.5 17.3 83.7% View Chart
P/BV x 2.8 1.4 203.9% View Chart
Dividend Yield % 1.5 1.1 130.0%  

Financials

 CADILA HEALTHCARE   TTK HEALTHCARE
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-18
TTK HEALTHCARE
Mar-19
CADILA HEALTHCARE/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs5581,215 45.9%   
Low Rs362610 59.3%   
Sales per share (Unadj.) Rs116.3444.4 26.2%  
Earnings per share (Unadj.) Rs17.917.2 103.6%  
Cash flow per share (Unadj.) Rs23.127.6 83.7%  
Dividends per share (Unadj.) Rs3.505.00 70.0%  
Dividend yield (eoy) %0.80.5 138.9%  
Book value per share (Unadj.) Rs85.4177.9 48.0%  
Shares outstanding (eoy) m1,023.7414.13 7,245.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.02.1 192.5%   
Avg P/E ratio x25.752.9 48.6%  
P/CF ratio (eoy) x19.933.0 60.2%  
Price / Book Value ratio x5.45.1 105.0%  
Dividend payout %19.629.0 67.6%   
Avg Mkt Cap Rs m470,66412,894 3,650.2%   
No. of employees `00011.82.3 511.2%   
Total wages/salary Rs m18,5451,307 1,418.9%   
Avg. sales/employee Rs Th10,072.72,715.7 370.9%   
Avg. wages/employee Rs Th1,569.1565.3 277.6%   
Avg. net profit/employee Rs Th1,547.7105.4 1,468.3%   
INCOME DATA
Net Sales Rs m119,0496,279 1,896.0%  
Other income Rs m1,13278 1,460.6%   
Total revenues Rs m120,1816,356 1,890.7%   
Gross profit Rs m28,475496 5,745.6%  
Depreciation Rs m5,388147 3,672.8%   
Interest Rs m91134 2,695.3%   
Profit before tax Rs m23,308393 5,936.8%   
Minority Interest Rs m6280-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,644149 3,790.5%   
Profit after tax Rs m18,292244 7,505.9%  
Gross profit margin %23.97.9 303.0%  
Effective tax rate %24.237.9 63.8%   
Net profit margin %15.43.9 395.9%  
BALANCE SHEET DATA
Current assets Rs m82,0052,717 3,018.0%   
Current liabilities Rs m60,7201,571 3,865.5%   
Net working cap to sales %17.918.3 97.9%  
Current ratio x1.41.7 78.1%  
Inventory Days Days7332 227.5%  
Debtors Days Days9847 210.7%  
Net fixed assets Rs m83,703991 8,446.3%   
Share capital Rs m1,024141 724.7%   
"Free" reserves Rs m86,4212,373 3,641.9%   
Net worth Rs m87,4452,514 3,477.9%   
Long term debt Rs m25,5513 751,500.0%   
Total assets Rs m180,6534,158 4,344.6%  
Interest coverage x26.612.6 210.7%   
Debt to equity ratio x0.30 21,607.8%  
Sales to assets ratio x0.71.5 43.6%   
Return on assets %10.66.7 159.3%  
Return on equity %20.99.7 215.8%  
Return on capital %22.016.9 129.8%  
Exports to sales %03.6 0.0%   
Imports to sales %00.5 0.0%   
Exports (fob) Rs mNA225 0.0%   
Imports (cif) Rs mNA31 0.0%   
Fx inflow Rs m42,683225 18,953.4%   
Fx outflow Rs m11,24271 15,809.3%   
Net fx Rs m31,441154 20,404.3%   
CASH FLOW
From Operations Rs m9,193173 5,310.8%  
From Investments Rs m-9,73797 -10,090.2%  
From Financial Activity Rs m515-307 -167.6%  
Net Cashflow Rs m-29-38 76.9%  

Share Holding

Indian Promoters % 74.8 65.4 114.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 3.7 224.3%  
FIIs % 5.9 5.2 113.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 25.8 42.6%  
Shareholders   44,069 12,723 346.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   TORRENT PHARMA  NATCO PHARMA  DIVIS LABORATORIES  PFIZER  ALKEM LABORATORIES  

Compare CADILA HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Climbs 200 Points; Yes Bank and Reliance Industries Top Gainers(12:30 pm)

Share markets in India are presently trading on a positive note. All sectoral indices are trading in green with stocks in the capital goods sector.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 28.9% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CADILA HEALTHCARE has posted a net profit of Rs 3 bn (down 28.9% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 21.0% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 21.0% YoY). Sales on the other hand came in at Rs 37 bn (up 14.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Oct 18, 2019 02:53 PM

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE - AJANTA PHARMA COMPARISON

COMPARE CADILA HEALTHCARE WITH

MARKET STATS